PCVX vs AMGN: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Amgen Inc in 2026
PCVX
Vaxcyte Inc
$62.35
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | PCVX | AMGN | Winner |
|---|---|---|---|
| Market Cap | $9.03B | $188.34B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.22 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze PCVX
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or AMGN a better investment?
Comparing PCVX and AMGN: Vaxcyte Inc has a market cap of $9.03B while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and AMGN?
PCVX (Vaxcyte Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for PCVX.
Which company is more profitable: PCVX or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for PCVX.
Which is the larger company: PCVX or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $9.03B for PCVX.
Should I buy PCVX or AMGN in 2026?
Both PCVX and AMGN have investment merit. PCVX trades at $62.35 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and AMGN stock?
Key differences: Market Cap ($9.03B vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).